Shreya Life Sciences acquired Rallis India and Plethico Pharmaceuticals, with an aim to reach across millions with their unique human insulin products.
CMD - Sujit Kumar Singh
Business - Insulin products
Performance:
Recovering from their financial blackout, Shreya Life Sciences is about to sucessfully launch its oral Recosulin product under the DCGI guidance.
CMD - Sujit Kumar Singh
Business - Insulin products
Performance:
Recovering from their financial blackout, Shreya Life Sciences is about to sucessfully launch its oral Recosulin product under the DCGI guidance.
No comments:
Post a Comment